Related references
Note: Only part of the references are listed.Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
Peter Muench et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Humoral Immune Response to SARS-CoV-2 Comparative Clinical Performance of Seven Commercial Serology Tests
Pauline H. Herroelen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer
Clarence W. Chan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis
Paulin N. Essone et al.
SCIENTIFIC REPORTS (2019)
Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination
Victoria Bradt et al.
NPJ VACCINES (2019)
Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells
Wilfried A. A. Saron et al.
SCIENCE ADVANCES (2018)
Pre-existing immunity against vaccine vectors - friend or foe?
Manvendra Saxena et al.
MICROBIOLOGY-SGM (2013)
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus.
Kathy Hancock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
